Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Pallmann

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
BJS Open|December 1, 2021
The PERCEIVE quantitative study: PrEdiction of Risk and Communication of outcome following major lower-limb amputation: protocol for a collaboratiVE studyBrenig L Gwilym, Cherry-Ann Waldron, Emma Thomas-Jones, et al.
BMJ Open|January 26, 2022
Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trialCherry-Ann Waldron, Emma Thomas-Jones, Jolanta Bernatoniene, et al.
BMJ Open|December 19, 2023
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study)Josie Henley, Lucy Brookes-Howell, Joanne Euden, et al.
Trials|November 22, 2023
Correction: Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingMartin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, et al.
The British Journal of Surgery|September 6, 2022
Short-term risk prediction after major lower limb amputation: PERCEIVE studyBrenig L Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
Trials|October 5, 2023
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingMartin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, et al.
BMC Pregnancy and Childbirth|May 16, 2021
Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational studySarah F Bell, Rachel E Collis, Philip Pallmann, et al.
BJS Open|January 24, 2024
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE studyBrenig Llwyd Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
BMC Medicine|August 9, 2022
Practical guidance for planning resources required to support publicly-funded adaptive clinical trialsJames M S Wason, Munyaradzi Dimairo, Katie Biggs, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
BJS Open|December 1, 2021
The PERCEIVE quantitative study: PrEdiction of Risk and Communication of outcome following major lower-limb amputation: protocol for a collaboratiVE studyBrenig L Gwilym, Cherry-Ann Waldron, Emma Thomas-Jones, et al.
BMJ Open|January 26, 2022
Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trialCherry-Ann Waldron, Emma Thomas-Jones, Jolanta Bernatoniene, et al.
BMJ Open|December 19, 2023
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study)Josie Henley, Lucy Brookes-Howell, Joanne Euden, et al.
Trials|November 22, 2023
Correction: Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingMartin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, et al.
The British Journal of Surgery|September 6, 2022
Short-term risk prediction after major lower limb amputation: PERCEIVE studyBrenig L Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
Trials|October 5, 2023
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingMartin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, et al.
BMC Pregnancy and Childbirth|May 16, 2021
Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational studySarah F Bell, Rachel E Collis, Philip Pallmann, et al.
BJS Open|January 24, 2024
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE studyBrenig Llwyd Gwilym, Philip Pallmann, Cherry-Ann Waldron, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
BMC Medicine|August 9, 2022
Practical guidance for planning resources required to support publicly-funded adaptive clinical trialsJames M S Wason, Munyaradzi Dimairo, Katie Biggs, et al.
Pageof 8